| scholarly article | Q13442814 |
| P2093 | author name string | Allan Bradley | |
| Junji Takeda | |||
| Roland Rad | |||
| Kosuke Yusa | |||
| P2860 | cites work | Generation of an inducible and optimized piggyBac transposon system. | Q40118227 |
| Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice | Q40386192 | ||
| Splinkerettes--improved vectorettes for greater efficiency in PCR walking. | Q40393976 | ||
| Precise excision of TTAA-specific lepidopteran transposons piggyBac (IFP2) and tagalong (TFP3) from the baculovirus genome in cell lines from two species of Lepidoptera | Q41201975 | ||
| Generation of induced pluripotent stem cells in the absence of drug selection | Q41583804 | ||
| Transposon mutagenesis of baculoviruses: analysis of Trichoplusia ni transposon IFP2 insertions within the FP-locus of nuclear polyhedrosis viruses | Q42642012 | ||
| Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector | Q45874327 | ||
| Two Supporting Factors Greatly Improve the Efficiency of Human iPSC Generation | Q57974225 | ||
| Virus-free induction of pluripotency and subsequent excision of reprogramming factors | Q24644686 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Generation of germline-competent induced pluripotent stem cells | Q28131699 | ||
| Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes | Q29614341 | ||
| Generation of mouse induced pluripotent stem cells without viral vectors | Q29614342 | ||
| Induced pluripotent stem cells generated without viral integration | Q29614343 | ||
| Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds | Q29614344 | ||
| Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts | Q29614794 | ||
| A highly efficient recombineering-based method for generating conditional knockout mutations | Q29615157 | ||
| Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 | Q29617098 | ||
| Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells | Q29617246 | ||
| piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells | Q29619409 | ||
| A drug-inducible system for direct reprogramming of human somatic cells to pluripotency | Q33898136 | ||
| Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia | Q34338550 | ||
| Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues | Q34417194 | ||
| Generation of pluripotent stem cells from adult mouse liver and stomach cells | Q34750323 | ||
| Strategies and new developments in the generation of patient-specific pluripotent stem cells | Q34764937 | ||
| Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency | Q34771507 | ||
| Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse | Q36512789 | ||
| piggyBac can bypass DNA synthesis during cut and paste transposition | Q36570713 | ||
| Chromosomal transposition of PiggyBac in mouse embryonic stem cells | Q36737096 | ||
| Reprogramming of murine and human somatic cells using a single polycistronic vector | Q37068363 | ||
| A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types | Q37124767 | ||
| Retrovirus-induced oncogenesis and safety of retroviral vectors. | Q37284877 | ||
| Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. | Q39677670 | ||
| Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells | Q39997700 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 363-369 | |
| P577 | publication date | 2009-03-31 | |
| P1433 | published in | Nature Methods | Q680640 |
| P1476 | title | Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon | |
| P478 | volume | 6 |
| Q36839635 | A Mammalian enhancer trap resource for discovering and manipulating neuronal cell types |
| Q54961854 | A Modified Monomeric Red Fluorescent Protein Reporter for Assessing CRISPR Activity. |
| Q35774048 | A Multifunctional Mutagenesis System for Analysis of Gene Function in Zebrafish |
| Q60934566 | A common molecular logic determines embryonic stem cell self-renewal and reprogramming |
| Q38736148 | A decade of transcription factor-mediated reprogramming to pluripotency |
| Q38601085 | A developmental framework for induced pluripotency |
| Q42321893 | A further analysis of olfactory cortex development |
| Q36165855 | A highly efficient method for generation of therapeutic quality human pluripotent stem cells by using naive induced pluripotent stem cells nucleus for nuclear transfer |
| Q33785567 | A hyperactive piggyBac transposase for mammalian applications |
| Q30539955 | A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation. |
| Q37678168 | A method for stable transgenesis of radial glia lineage in rat neocortex by piggyBac mediated transposition |
| Q38786732 | A new era of disease modeling and drug discovery using induced pluripotent stem cells |
| Q30557696 | A novel assay for quantifying the number of plasmids encapsulated by polymer nanoparticles |
| Q35107224 | A nucleolus-predominant piggyBac transposase, NP-mPB, mediates elevated transposition efficiency in mammalian cells |
| Q51075110 | A piggyBac transposon- and gateway-enhanced system for efficient BAC transgenesis. |
| Q55380056 | A platform of BRET-FRET hybrid biosensors for optogenetics, chemical screening, and in vivo imaging. |
| Q26851933 | A poor imitation of a natural process: a call to reconsider the iPSC engineering technique |
| Q38236662 | A practical guide to induced pluripotent stem cell research using patient samples |
| Q37336915 | A primary role of TET proteins in establishment and maintenance of De Novo bivalency at CpG islands |
| Q34734737 | A proposal of a novel experimental procedure to genetically identify disease gene loci in humans |
| Q34712517 | A site-specific recombinase-based method to produce antibiotic selectable marker free transgenic cattle |
| Q33961690 | A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells. |
| Q27323376 | A universal vector for high-efficiency multi-fragment recombineering of BACs and knock-in constructs |
| Q28740795 | A virus-free poly-promoter vector induces pluripotency in quiescent bovine cells under chemically defined conditions of dual kinase inhibition |
| Q42523299 | Achievements and challenges in bioartificial kidney development |
| Q41871045 | Activated Ras protein accelerates cell cycle progression to perturb Madin-Darby canine kidney cystogenesis |
| Q49888527 | Acute compressive stress activates RHO/ROCK-mediated cellular processes. |
| Q39723914 | Adult Olfactory Bulb Interneuron Phenotypes Identified by Targeting Embryonic and Postnatal Neural Progenitors. |
| Q34018901 | Adult mice generated from induced pluripotent stem cells |
| Q37850732 | Advancements in reprogramming strategies for the generation of induced pluripotent stem cells |
| Q38187715 | All roads lead to induced pluripotent stem cells: the technologies of iPSC generation. |
| Q35082744 | Alternative sources of pluripotent stem cells: ethical and scientific issues revisited |
| Q33580353 | An optimized, broadly applicable piggyBac transposon induction system |
| Q38133156 | Applying horizontal gene transfer phenomena to enhance non-viral gene therapy |
| Q37742101 | Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies |
| Q36438871 | Axon sorting within the spinal cord marginal zone via Robo-mediated inhibition of N-cadherin controls spinocerebellar tract formation |
| Q89943000 | Baboon induced pluripotent stem cell generation by piggyBac transposition of reprogramming factors |
| Q34463138 | Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. |
| Q37642897 | CLoNe is a new method to target single progenitors and study their progeny in mouse and chick |
| Q41125370 | CMD kinetics and regenerative medicine |
| Q27002327 | Can pluripotent stem cells be used in cell-based therapy? |
| Q36218706 | Cell Density-Dependent Increase in Tyrosine-Monophosphorylated ERK2 in MDCK Cells Expressing Active Ras or Raf. |
| Q42185321 | Cellular reprogramming employing recombinant sox2 protein |
| Q38044447 | Cellular reprogramming: a new approach to modelling Parkinson's disease. |
| Q46388196 | Chick derived induced pluripotent stem cells by the poly-cistronic transposon with enhanced transcriptional activity |
| Q36144775 | Chimeric piggyBac transposases for genomic targeting in human cells |
| Q30604745 | Combining TGF-β signal inhibition and connexin43 silencing for iPSC induction from mouse cardiomyocytes |
| Q40139400 | Comparative analysis of chimeric ZFP-, TALE- and Cas9-piggyBac transposases for integration into a single locus in human cells |
| Q24631012 | Comparative analysis of transposable element vector systems in human cells |
| Q46709944 | Competing memories of mitogen and p53 signalling control cell-cycle entry |
| Q26858869 | Concise review: The magic act of generating induced pluripotent stem cells: many rabbits in the hat |
| Q37872272 | Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency |
| Q34919971 | Contribution of Mouse Embryonic Stem Cells and Induced Pluripotent Stem Cells to Chimeras through Injection and Coculture of Embryos. |
| Q33625447 | Contribution of tumor heterogeneity in a new animal model of CNS tumors |
| Q38372922 | Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine. |
| Q45862717 | Current applications of transposons in mouse genetics |
| Q38672652 | Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells |
| Q38836237 | DNA Transposition at Work |
| Q37606888 | DNA transposition by protein transduction of the piggyBac transposase from lentiviral Gag precursors |
| Q28751993 | DNA transposons: nature and applications in genomics |
| Q37844151 | Defining pluripotent stem cells through quantitative proteomic analysis. |
| Q37998955 | Delineating nuclear reprogramming |
| Q39691935 | Dental pulp cells for induced pluripotent stem cell banking. |
| Q47296243 | Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent Advances |
| Q37233718 | Derivation of induced pluripotent stem cells from pig somatic cells |
| Q34345526 | Development of an all-in-one inducible lentiviral vector for gene specific analysis of reprogramming |
| Q35579824 | Development of an optimized backbone of FRET biosensors for kinases and GTPases |
| Q34050308 | Direct interrogation of DNA content distribution in nanoparticles by a novel microfluidics-based single-particle analysis |
| Q34599786 | ECM-dependent HIF induction directs trophoblast stem cell fate via LIMK1-mediated cytoskeletal rearrangement |
| Q37489360 | Effective Targeted Gene Knockdown in Mammalian Cells Using the piggyBac Transposase-based Delivery System |
| Q34040833 | Efficient generation human induced pluripotent stem cells from human somatic cells with Sendai-virus. |
| Q33972190 | Efficient germ-line transmission obtained with transgene-free induced pluripotent stem cells |
| Q85821747 | Efficient p53 gene targeting by homologous recombination in rat-induced pluripotent stem cells |
| Q47594549 | Efficient synthesis of phycocyanobilin in mammalian cells for optogenetic control of cell signaling |
| Q90576157 | Emerging roles of Myc in stem cell biology and novel tumor therapies |
| Q42571070 | Endogenous Transposase Source in Human Cells Mobilizes piggyBac Transposons |
| Q38126465 | Engineering subtle targeted mutations into the mouse genome |
| Q46312471 | Epigenetic foundations of pluripotent stem cells that recapitulate in vivo pluripotency |
| Q38962333 | Epigenome rejuvenation: HP1β mobility as a measure of pluripotent and senescent chromatin ground states |
| Q35089047 | Evaluating the potential for undesired genomic effects of the piggyBac transposon system in human cells |
| Q34082195 | Excision efficiency is not strongly coupled to transgenic rate: cell type-dependent transposition efficiency of sleeping beauty and piggyBac DNA transposons |
| Q38337835 | Exogenous enzymes upgrade transgenesis and genetic engineering of farm animals |
| Q38255828 | Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9. |
| Q37779125 | Experimental approaches for the generation of induced pluripotent stem cells. |
| Q33767614 | Extracortical origin of some murine subplate cell populations |
| Q37055304 | Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells |
| Q30524908 | Feeder-free derivation of human induced pluripotent stem cells with messenger RNA |
| Q42238143 | Feeder-free reprogramming of human fibroblasts with messenger RNA. |
| Q38079631 | Fluorescence resonance energy transfer imaging of cell signaling from in vitro to in vivo: basis of biosensor construction, live imaging, and image processing |
| Q34408810 | Footprint-free human induced pluripotent stem cells from articular cartilage with redifferentiation capacity: a first step toward a clinical-grade cell source |
| Q37810612 | From stem cells to neural networks: recent advances and perspectives for neurodevelopmental disorders |
| Q38871443 | Full biological characterization of human pluripotent stem cells will open the door to translational research |
| Q27024431 | Functional cardiac tissue engineering |
| Q45874318 | Gene and Cell Therapy for β-Thalassemia and Sickle Cell Disease with Induced Pluripotent Stem Cells (iPSCs): The Next Frontier |
| Q38155214 | Gene delivery techniques for adult stem cell-based regenerative therapy |
| Q39187981 | Generation and characterization of bat-induced pluripotent stem cells |
| Q45351750 | Generation and characterization of virus-free reprogrammed melanoma cells by the piggyBac transposon |
| Q37763190 | Generation and genetic modification of induced pluripotent stem cells |
| Q35750050 | Generation of Naïve Bovine Induced Pluripotent Stem Cells Using PiggyBac Transposition of Doxycycline-Inducible Transcription Factors. |
| Q48365947 | Generation of Transplantable Retinal Photoreceptors from a Current Good Manufacturing Practice-Manufactured Human Induced Pluripotent Stem Cell Line. |
| Q34391043 | Generation of a dual-color reporter mouse line to monitor spermatogenesis in vivo. |
| Q52934589 | Generation of induced pluripotent stem cells from domestic goats. |
| Q34320340 | Generation of induced pluripotent stem cells using site-specific integration with phage integrase |
| Q37205314 | Generation of integration-free and region-specific neural progenitors from primate fibroblasts |
| Q39089967 | Generation of mouse induced pluripotent stem cells by protein transduction |
| Q40291779 | Generation of non-viral, transgene-free hepatocyte like cells with piggyBac transposon. |
| Q43729214 | Generation of precise point mutation mice by footprintless genome modification. |
| Q35796924 | Generation of stable pluripotent stem cells from NOD mouse tail-tip fibroblasts |
| Q53088533 | Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector. |
| Q42118625 | Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. |
| Q24604856 | Genome 10K: a proposal to obtain whole-genome sequence for 10,000 vertebrate species |
| Q30987060 | Genome-wide forward genetic screens in mouse ES cells. |
| Q35096218 | Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library |
| Q28740951 | Genome-wide target profiling of piggyBac and Tol2 in HEK 293: pros and cons for gene discovery and gene therapy |
| Q34992247 | Germline competence of mouse ES and iPS cell lines: Chimera technologies and genetic background. |
| Q28505980 | HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor Growth |
| Q90859690 | HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer |
| Q35416543 | Human endometrial cells express elevated levels of pluripotent factors and are more amenable to reprogramming into induced pluripotent stem cells |
| Q33560423 | Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders |
| Q36090810 | Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway |
| Q41982351 | Hyperactive mariner transposons are created by mutations that disrupt allosterism and increase the rate of transposon end synapsis |
| Q35823889 | Hyperactive piggyBac gene transfer in human cells and in vivo. |
| Q37419175 | Hypoxia promotes CEMP1 expression and induces cementoblastic differentiation of human dental stem cells in an HIF-1-dependent manner |
| Q38483743 | Identification of Ccr4-not complex components as regulators of transition from partial to genuine induced pluripotent stem cells |
| Q33826708 | Immortalized prairie vole-derived fibroblasts (VMF-K4DTs) can be transformed into pluripotent stem cells and provide a useful tool with which to determine optimal reprogramming conditions |
| Q93080681 | In Vivo Piggybac-Based Gene Delivery towards Murine Pancreatic Parenchyma Confers Sustained Expression of Gene of Interest |
| Q33951804 | In vivo reprogramming of adult somatic cells to pluripotency by overexpression of Yamanaka factors |
| Q38259745 | Increasing doublecortin expression promotes migration of human embryonic stem cell-derived neurons |
| Q26775061 | Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges |
| Q38700801 | Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications |
| Q40097606 | Induced Pluripotent Stem Cells With Six Reprogramming Factors From Prairie Vole, Which Is an Animal Model for Social Behaviors |
| Q38242113 | Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases |
| Q38014843 | Induced Pluripotent Stem Cells: Problems and Advantages when Applying them in Regenerative Medicine |
| Q94527397 | Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy |
| Q34206028 | Induced pluripotency: history, mechanisms, and applications |
| Q37800367 | Induced pluripotent stem (iPS) cells: an up-to-the-minute review |
| Q39569381 | Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts |
| Q33830512 | Induced pluripotent stem cell models of lysosomal storage disorders |
| Q26823333 | Induced pluripotent stem cell technology and direct conversion: new possibilities to study and treat Parkinson's disease |
| Q37306665 | Induced pluripotent stem cells and the stability of the differentiated state |
| Q39025414 | Induced pluripotent stem cells as a new getaway for bone tissue engineering: A systematic review. |
| Q38041929 | Induced pluripotent stem cells for cardiac repair |
| Q38203865 | Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges. |
| Q34400271 | Induced pluripotent stem cells in dermatology: potentials, advances, and limitations |
| Q37239088 | Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases |
| Q36131883 | Induced pluripotent stem cells to model and treat neurogenetic disorders |
| Q37779822 | Induced pluripotent stem cells--alchemist's tale or clinical reality? |
| Q35205657 | Induced pluripotent stem cells: Mechanisms, achievements and perspectives in farm animals |
| Q35037783 | Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery |
| Q37824869 | Induced pluripotent stem cells: emerging techniques for nuclear reprogramming |
| Q38869452 | Inducible Transgene Expression in Human iPS Cells Using Versatile All-in-One piggyBac Transposons |
| Q30420062 | Inducible pluripotent stem cells: not quite ready for prime time? |
| Q31037788 | Integration-free iPS cells engineered using human artificial chromosome vectors |
| Q58616503 | Intravenous Delivery of Bac Transposons as a Useful Tool for Liver-Specific Gene-Switching |
| Q36222369 | Intravital Förster resonance energy transfer imaging reveals osteopontin-mediated polymorphonuclear leukocyte activation by tumor cell emboli |
| Q47556660 | Introduction of Exogenous HSV-TK Suicide Gene Increases Safety of Keratinocyte-Derived Induced Pluripotent Stem Cells by Providing Genetic "Emergency Exit" Switch. |
| Q35453993 | KLF4 N-terminal variance modulates induced reprogramming to pluripotency |
| Q50130161 | LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway |
| Q39666146 | Late passage human fibroblasts induced to pluripotency are capable of directed neuronal differentiation. |
| Q39149055 | Lineage-specific purification of neural stem/progenitor cells from differentiated mouse induced pluripotent stem cells |
| Q42385640 | Live imaging of transforming growth factor-β activated kinase 1 activation in Lewis lung carcinoma 3LL cells implanted into syngeneic mice and treated with polyinosinic:polycytidylic acid |
| Q38810077 | Locally excitable Cdc42 signals steer cells during chemotaxis. |
| Q64898599 | Lzts1 controls both neuronal delamination and outer radial glial-like cell generation during mammalian cerebral development. |
| Q96302601 | MCM8IP activates the MCM8-9 helicase to promote DNA synthesis and homologous recombination upon DNA damage |
| Q38585848 | Manipulating piggyBac transposon chromosomal integration site selection in human cells |
| Q37953325 | Mechanism and methods to induce pluripotency |
| Q34799507 | Mechanistic insights into reprogramming to induced pluripotency. |
| Q36039878 | Mesenchymal to Epithelial Transition Induced by Reprogramming Factors Attenuates the Malignancy of Cancer Cells |
| Q37845645 | Methods for making induced pluripotent stem cells: reprogramming à la carte |
| Q38332490 | Methods of induced pluripotent stem cells for clinical application |
| Q34388582 | MiR-25 regulates Wwp2 and Fbxw7 and promotes reprogramming of mouse fibroblast cells to iPSCs. |
| Q28587773 | MicroRNAs are indispensable for reprogramming mouse embryonic fibroblasts into induced stem cell-like cells |
| Q39077742 | Minimal piggyBac vectors for chromatin integration |
| Q39826562 | Mobilization of giant piggyBac transposons in the mouse genome |
| Q92570903 | Modeling blood diseases with human induced pluripotent stem cells |
| Q38941071 | Modes of TAL effector-mediated repression |
| Q33667400 | Multiplexed transposon-mediated stable gene transfer in human cells |
| Q59072379 | Myocardial Reprogramming Medicine: The Development, Application, and Challenge of Induced Pluripotent Stem Cells |
| Q26777286 | Neuroprotective therapies in glaucoma: II. Genetic nanotechnology tools |
| Q37840172 | New approaches for the generation of induced pluripotent stem cells |
| Q38106712 | No factor left behind: generation of transgene-free induced pluripotent stem cells |
| Q92690625 | Non-coding cis-element of Period2 is essential for maintaining organismal circadian behaviour and body temperature rhythmicity |
| Q42566630 | Non-viral iPSCs: a safe way for therapy? |
| Q38519892 | Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies. |
| Q21133540 | Nuclear localization of the mitochondrial factor HIGD1A during metabolic stress |
| Q38175498 | Nuclease-mediated genome editing: At the front-line of functional genomics technology |
| Q64239062 | OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates |
| Q47114932 | On-demand optogenetic activation of human stem-cell-derived neurons |
| Q38698890 | Overexpression of WDFY2 inhibits prostate cancer cell growth and migration via inactivation of Akt pathway |
| Q37893537 | PET molecular imaging in stem cell therapy for neurological diseases |
| Q59335760 | Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease |
| Q41836711 | Patient-specific pluripotent stem cells in neurological diseases |
| Q45366611 | Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells |
| Q64972420 | PiggyBac Transposon-Mediated Transgenesis in the Pacific Oyster (Crassostrea gigas) - First Time in Mollusks. |
| Q26767014 | PiggyBac transposon vectors: the tools of the human gene encoding |
| Q33622722 | PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer |
| Q36091791 | PiggyBac transposon-mediated gene delivery efficiently generates stable transfectants derived from cultured primary human deciduous tooth dental pulp cells (HDDPCs) and HDDPC-derived iPS cells |
| Q35101962 | PiggyBac transposon-mediated, reversible gene transfer in human embryonic stem cells |
| Q37776444 | Pluripotent Stem Cells: Origin, Maintenance and Induction |
| Q34833754 | Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors |
| Q36944724 | Pluripotent stem cells and livestock genetic engineering. |
| Q37891178 | Pluripotent stem cells and reprogrammed cells in farm animals. |
| Q91688675 | Potential for Isolation of Immortalized Hepatocyte Cell Lines by Liver-Directed In Vivo Gene Delivery of Transposons in Mice |
| Q36911697 | Potential of herpesvirus saimiri-based vectors to reprogram a somatic Ewing's sarcoma family tumor cell line |
| Q37772900 | Potential of human induced pluripotent stem cells derived from blood and other postnatal cell types |
| Q98726590 | Potential of transposon-mediated cellular reprogramming towards cell-based therapies |
| Q34541218 | Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity |
| Q34806779 | Precise marker excision system using an animal-derived piggyBac transposon in plants. |
| Q90269934 | Principles of Genetic Engineering |
| Q37697617 | Progress and promise towards safe induced pluripotent stem cells for therapy |
| Q34069504 | Promotion of direct reprogramming by transformation-deficient Myc. |
| Q38031618 | Prospects and challenges of reprogrammed cells in hematology and oncology. |
| Q34056400 | Quantitative in vivo fluorescence cross-correlation analyses highlight the importance of competitive effects in the regulation of protein-protein interactions |
| Q34263223 | RNA interference is responsible for reduction of transgene expression after Sleeping Beauty transposase mediated somatic integration |
| Q38121503 | RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications. |
| Q37180598 | Rap1 potentiates endothelial cell junctions by spatially controlling myosin II activity and actin organization |
| Q34028925 | Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. |
| Q38775692 | Rational Development of A Polycistronic Plasmid with A CpG-Free Bacterial Backbone as A Potential Tool for Direct Reprogramming. |
| Q65002709 | Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders. |
| Q38017202 | Recent developments in transposon-mediated gene therapy |
| Q37770372 | Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration |
| Q34479014 | Rederivation of transgenic mice from iPS cells derived from frozen tissue |
| Q41811170 | Removal of reprogramming transgenes improves the tissue reconstitution potential of keratinocytes generated from human induced pluripotent stem cells |
| Q36201012 | Reprogramming Roadblocks Are System Dependent |
| Q39463637 | Reprogramming human fibroblasts to pluripotency using modified mRNA. |
| Q35892713 | Reprogramming of mouse, rat, pig, and human fibroblasts into iPS cells |
| Q28074002 | Retroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectives |
| Q58099296 | SMAD4 is essential for human cardiac mesodermal precursor cell formation |
| Q48925635 | Seamless genome editing in human pluripotent stem cells using custom endonuclease-based gene targeting and the piggyBac transposon |
| Q42146807 | Selection via pluripotency-related transcriptional screen minimizes the influence of somatic origin on iPSC differentiation propensity |
| Q41141279 | Selective cell targeting and lineage tracing of human induced pluripotent stem cells using recombinant avian retroviruses. |
| Q49551970 | Sequence-specific DNA binding activity of the cross-brace zinc finger motif of the piggyBac transposase |
| Q37368244 | Serum-free spheroid suspension culture maintains mesenchymal stem cell proliferation and differentiation potential |
| Q36228002 | Simultaneous live imaging of the transcription and nuclear position of specific genes. |
| Q34620774 | Single-gene transgenic mouse strains for reprogramming adult somatic cells |
| Q41831020 | Site-specific recombinase strategy to create induced pluripotent stem cells efficiently with plasmid DNA. |
| Q38970768 | Sleeping Beauty transposition: from biology to applications. |
| Q41999327 | Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells. |
| Q39670673 | Slingshot: a PiggyBac based transposon system for tamoxifen-inducible 'self-inactivating' insertional mutagenesis |
| Q33981293 | Somatic genetics empowers the mouse for modeling and interrogating developmental and disease processes |
| Q41102498 | Spatiotemporal analyses of neural lineages after embryonic and postnatal progenitor targeting combining different reporters |
| Q41944663 | Specialized filopodia direct long-range transport of SHH during vertebrate tissue patterning |
| Q33871311 | Spinal muscular atrophy: mechanisms and therapeutic strategies |
| Q27028106 | Stem cell sources for vascular tissue engineering and regeneration |
| Q38279899 | Stem cell therapies for treating osteoarthritis: prescient or premature? |
| Q27024267 | Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet? |
| Q38063950 | Stem cells therapy for cardiovascular repair in ischemic heart disease: How to predict and secure optimal outcome? |
| Q30599987 | Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells |
| Q42218179 | Strategies for rapidly mapping proviral integration sites and assessing cardiogenic potential of nascent human induced pluripotent stem cell clones |
| Q97529550 | Structural basis of seamless excision and specific targeting by piggyBac transposase |
| Q35213346 | Sustained high level transgene expression in mammalian cells mediated by the optimized piggyBac transposon system |
| Q38040207 | Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury. |
| Q26827749 | THERAPY OF ENDOCRINE DISEASE: Islet transplantation for type 1 diabetes: so close and yet so far away |
| Q50496178 | Targeted disruption of exogenous EGFP gene in medaka using zinc-finger nucleases. |
| Q24634829 | Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells |
| Q58914898 | Technological progress in generation of induced pluripotent stem cells for clinical applications |
| Q88608509 | The Dorsal Wave of Neocortical Oligodendrogenesis Begins Embryonically and Requires Multiple Sources of Sonic Hedgehog |
| Q41334055 | The Generation of Mouse and Human Huntington Disease iPS Cells Suitable for In vitro Studies on Huntingtin Function |
| Q38024317 | The evolving field of induced pluripotency: recent progress and future challenges |
| Q21092858 | The mouse genetics toolkit: revealing function and mechanism |
| Q30570747 | The parallel growth of motoneuron axons with the dorsal aorta depends on Vegfc/Vegfr3 signaling in zebrafish |
| Q39790794 | The piggyBac transposon displays local and distant reintegration preferences and can cause mutations at noncanonical integration sites |
| Q37286336 | The piggyBac-Based Gene Delivery System Can Confer Successful Production of Cloned Porcine Blastocysts with Multigene Constructs |
| Q35981667 | The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk |
| Q91659773 | The role of clonal communication and heterogeneity in breast cancer |
| Q35882655 | Therapeutic potential of lung epithelial progenitor cells derived from embryonic and induced pluripotent stem cells |
| Q38168206 | Therapeutic transdifferentiation: can we generate cardiac tissue rather than scar after myocardial injury? |
| Q34034314 | Towards optimising the production of and expression from polycistronic vectors in embryonic stem cells |
| Q34544205 | Transient expression of OCT4 is sufficient to allow human keratinocytes to change their differentiation pathway |
| Q24623786 | Transposon-mediated genome manipulation in vertebrates |
| Q50509483 | TrapSeq: An RNA Sequencing-Based Pipeline for the Identification of Gene-Trap Insertions in Mammalian Cells. |
| Q36028223 | Treatment with the cancer drugs decitabine and doxorubicin induces human skin keratinocytes to express Oct4 and the OCT4 regulator mir-145. |
| Q33908524 | Use of the 2A peptide for generation of multi-transgenic pigs through a single round of nuclear transfer. |
| Q38646228 | Utilization of Site-Specific Recombination in Biopharmaceutical Production |
| Q34745357 | Vector-free and transgene-free human iPS cells differentiate into functional neurons and enhance functional recovery after ischemic stroke in mice |
| Q38195650 | Vectorology and factor delivery in induced pluripotent stem cell reprogramming. |
| Q37131089 | Will brain cells derived from induced pluripotent stem cells or directly converted from somatic cells (iNs) be useful for schizophrenia research? |
| Q47913808 | Without a trace? PiggyBac-ing toward pluripotency |
| Q55398510 | iPS Cells-The Triumphs and Tribulations. |
| Q37805823 | iPS cells: a source of cardiac regeneration |
| Q64089132 | iPS-Cell Technology and the Problem of Genetic Instability—Can It Ever Be Safe for Clinical Use? |
| Q94564676 | iPSC-Derived Intestinal Organoids from Cystic Fibrosis Patients Acquire CFTR Activity upon TALEN-Mediated Repair of the p.F508del Mutation |
| Q38907215 | mTORC1 upregulation via ERK-dependent gene expression change confers intrinsic resistance to MEK inhibitors in oncogenic KRas-mutant cancer cells. |
| Q36950347 | piggyBac transposase tools for genome engineering |
| Q33822174 | piggyBac transposon-mediated long-term gene expression in mice. |
| Q36330999 | piggyBac-ing models and new therapeutic strategies |
| Q34730103 | β-catenin functions pleiotropically in differentiation and tumorigenesis in mouse embryo-derived stem cells |
Search more.